Within the hematoma, we identified a notable trend of CD8+ T cells transforming toward the CD8_GNLY subpopulation in patients with ICH, whereas the CD8+ T cells in controls were mainly retained in the naïve CD8_SELL state. The gene discussed is CD8A; the disease is hematoma.